Back to BlackRock Finance, Inc. BlackRock Finance, Inc.

TCRXTCRX
3 quarters

Position history for BlackRock Finance, Inc.BlackRock Finance, Inc.'s holdings in TSCAN THERAPEUTICS INC

BlackRock Finance, Inc. holds 4.5M shares of TCRX (TSCAN THERAPEUTICS INC), worth $26.1M as of 2024-Q2. The position was increased (+162.6% shares). TCRX represents 0.0% of BlackRock Finance, Inc.'s portfolio.

Current Value

$26.1M

Current Shares

4.5M

Total Value Change

+$16.4M

Total Shares Change

+2.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Increased
4.5M
+162.6%
$26.1M0.0%$5.85
46
2024-Q1
Increased
1.7M
+1.6%
$13.5M0.0%$7.94
28
2023-Q4
New
1.7M
-
$9.7M0.0%$5.83
38

Other major holders of TCRX: ADAGE CAPITAL PARTNERS GP, L.L.C., BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used